Clinical trials for glaucoma neuroprotection are not impossible
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine
Reference47 articles.
1. Neuroprotection in glaucoma: recent and future directions.;Danesh-Meyer;Curr Opin Ophthalmol,2011
2. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.;Artes;Invest Ophthalmol Vis Sci,2005
3. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures.;Am J Ophthalmol,1998
4. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.;Heijl;Arch Ophthalmol,2002
5. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.;Kass;Arch Ophthalmol,2002
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanisms contributing to inhibition of retinal ganglion cell death by cell permeable peptain-1 under glaucomatous stress;Cell Death Discovery;2024-06-28
2. Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma;Acta Neuropathologica Communications;2024-02-08
3. Endpoints for clinical trials in ophthalmology;Progress in Retinal and Eye Research;2023-11
4. Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma;Translational Vision Science & Technology;2023-10-31
5. Five-Year Visual Field Outcomes of the HORIZON Trial;American Journal of Ophthalmology;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3